T cell antigen discovery via Signaling and Antigen presenting Bifunctional Receptors

[1]  Jocelyn T. Kim,et al.  T cell antigen discovery via trogocytosis , 2019, Nature Methods.

[2]  D. Baltimore,et al.  T cell antigen discovery using signaling and antigen presenting bifunctional receptors (SABRs) , 2018, Protocol Exchange.

[3]  B. Walker,et al.  T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable , 2018, Proceedings of the National Academy of Sciences.

[4]  Purvesh Khatri,et al.  Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes , 2017, Cell.

[5]  Alok V. Joglekar,et al.  Personalized T cell-mediated cancer immunotherapy: progress and challenges. , 2017, Current opinion in biotechnology.

[6]  B. Roep,et al.  Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials , 2017, Front. Immunol..

[7]  J. Utikal,et al.  Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer , 2017, Nature.

[8]  A. Bentzen,et al.  Evolution of MHC-based technologies used for detection of antigen-responsive T cells , 2017, Cancer Immunology, Immunotherapy.

[9]  D. Baltimore,et al.  Preparation of peptide-MHC and T-cell receptor dextramers by biotinylated dextran doping. , 2017, BioTechniques.

[10]  V. Buchholz,et al.  T Cell Fate at the Single-Cell Level. , 2016, Annual review of immunology.

[11]  Deborah Hix,et al.  The immune epitope database (IEDB) 3.0 , 2014, Nucleic Acids Res..

[12]  Mark M. Davis,et al.  Deconstructing the Peptide-MHC Specificity of T Cell Recognition , 2014, Cell.

[13]  S. Rosenberg,et al.  Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer , 2014, Science.

[14]  Robert A Holt,et al.  Sequence analysis of T-cell repertoires in health and disease , 2013, Genome Medicine.

[15]  J. Castle,et al.  Exploiting the mutanome for tumor vaccination. , 2012, Cancer research.

[16]  E. Mardis,et al.  Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting , 2012, Nature.

[17]  O. Yang,et al.  Fine-tuning of T-cell receptor avidity to increase HIV epitope variant recognition by cytotoxic T lymphocytes , 2010, AIDS.

[18]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[19]  Qizhi Tang,et al.  The Foxp3+ regulatory T cell: a jack of all trades, master of regulation , 2008, Nature Immunology.

[20]  S. Rosenberg,et al.  Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.

[21]  Federica Cavallo,et al.  Vaccines for tumour prevention , 2006, Nature Reviews Cancer.

[22]  Yoshiyuki Nagai,et al.  Impaired Processing and Presentation of Cytotoxic-T-Lymphocyte (CTL) Epitopes Are Major Escape Mechanisms from CTL Immune Pressure in Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.

[23]  J. Thompson,et al.  Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Haidong Dong,et al.  Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.

[25]  L. Lybarger,et al.  Cutting Edge: Single-Chain Trimers of MHC Class I Molecules Form Stable Structures That Potently Stimulate Antigen-Specific T Cells and B Cells1 , 2002, The Journal of Immunology.

[26]  P. Klenerman,et al.  Tracking T cells with tetramers: new tales from new tools , 2002, Nature Reviews Immunology.

[27]  G. Zhu,et al.  Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.

[28]  R. Vile.  Faculty Opinions recommendation of IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. , 2001 .

[29]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[30]  S. Rowland-Jones,et al.  Distinct Recognition of Non-Clade B Human Immunodeficiency Virus Type 1 Epitopes by Cytotoxic T Lymphocytes Generated from Donors Infected in Africa , 1999, Journal of Virology.

[31]  L R Pease,et al.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. , 1998, Science.

[32]  J. Allison,et al.  Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.

[33]  P. Bruggen,et al.  Human tumor antigens recognized by T lymphocytes , 1996, The Journal of experimental medicine.

[34]  Dan R. Littman,et al.  Signal transduction by lymphocyte antigen receptors , 1994, Cell.

[35]  K. C. Tan,et al.  T cell clones generated from patients with type 1 diabetes using interleukin-2 proliferate to human islet antigens. , 1994, Autoimmunity.

[36]  Mark M. Davis,et al.  T-cell antigen receptor genes and T-cell recognition , 1988, Nature.